Literature DB >> 2220627

Results of percutaneous transluminal coronary angioplasty in patients greater than or equal to 65 years of age (from the 1985 to 1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry).

S F Kelsey1, D P Miller, R Holubkov, A S Lu, M J Cowley, D P Faxon, K M Detre.   

Abstract

The 1985 to 1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty (PTCA) Registry series of 1,801 initial procedures included 486 patients age greater than or equal to 65 years (elderly). In comparison to younger patients, a greater proportion of elderly patients were women and had unstable angina. Elderly patients had more history of hypertension and more history of congestive heart failure. Although the elderly had more extensive vessel disease, the numbers of lesions and vessels attempted with PTCA were similar in the older and younger cohorts. Angiographic success rates were similar for all age groups. Although complication rates in the catheterization laboratory did not differ, patients greater than or equal to 65 years were much more likely to require emergency coronary artery bypass graft surgery (CABG) (5.4 vs 2.8%, p less than 0.05) or elective CABG (3.9 vs 1.6%, p less than 0.01). The in-hospital death rate was considerably higher among the elderly (3.1 vs 0.2%, p less than 0.01). At 2-year follow-up, symptomatic status and cumulative rates of myocardial infarction, CABG and repeat PTCA were similar for elderly and younger patients. The death rate after 2 years was higher among elderly patients (8.8% of patients greater than or equal to 65 years vs 2.9% of patients less than 65 years, p less than 0.01). When the relative risk of death for the elderly was adjusted for factors more prevalent among those greater than or equal to 65 years (history of congestive heart failure, multivessel disease, unstable angina, history of hypertension and female gender), the relative risk remained significant but was substantially reduced (from 3.3 to 2.4).

Entities:  

Mesh:

Year:  1990        PMID: 2220627     DOI: 10.1016/0002-9149(90)90500-z

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Percutaneous coronary intervention in the elderly.

Authors:  Tracy Y Wang; Antonio Gutierrez; Eric D Peterson
Journal:  Nat Rev Cardiol       Date:  2010-12-07       Impact factor: 32.419

2.  Nuclear cardiology: the interventionalists' perspective.

Authors:  H L Haronian; H S Cabin
Journal:  J Nucl Cardiol       Date:  1994 Jul-Aug       Impact factor: 5.952

3.  Initial and long-term results of coronary angioplasty and coronary bypass surgery in patients of 75 or older.

Authors:  H Bonnier; C de Vries; R Michels; M el Gamal
Journal:  Br Heart J       Date:  1993-08

4.  In-Hospital Complications of Coronary Artery Bypass Graft Surgery in Patients Older Than 70 Years.

Authors:  Naser Safaie; Hossein Montazerghaem; Ahmadreza Jodati; Nasrollah Maghamipour
Journal:  J Cardiovasc Thorac Res       Date:  2015

5.  Outcome after Elective Percutaneous Coronary Intervention Depends on Age in Patients with Stable Coronary Artery Disease - An Analysis of Relative Survival in a Multicenter Cohort and an OCT Substudy.

Authors:  Christian Roth; Clemens Gangl; Daniel Dalos; Lisa Krenn; Sabine Scherzer; Anna Gerken; Martin Reinwein; Chao Zhang; Michael Hagmann; Thomas Wrba; Georg Delle-Karth; Thomas Neunteufl; Gerald Maurer; Paul Vock; Harald Mayr; Bernhard Frey; Rudolf Berger
Journal:  PLoS One       Date:  2016-04-22       Impact factor: 3.240

Review 6.  Big Data in Cardiology: State-of-Art and Future Prospects.

Authors:  Haijiang Dai; Arwa Younis; Jude Dzevela Kong; Luca Puce; Georges Jabbour; Hong Yuan; Nicola Luigi Bragazzi
Journal:  Front Cardiovasc Med       Date:  2022-04-01

Review 7.  Percutaneous Coronary Intervention in Elderly Patients with Coronary Chronic Total Occlusions: Current Evidence and Future Perspectives.

Authors:  Lei Guo; Hai-Chen Lv; Rong-Chong Huang
Journal:  Clin Interv Aging       Date:  2020-05-28       Impact factor: 4.458

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.